Cargando…
Second-generation antipsychotic use in borderline personality disorder: What are we targeting?
INTRODUCTION: Borderline personality disorder (BPD) is a personality disorder plagued with high rates of psychotropic polypharmacy. Estimates show that second-generation antipsychotics (SGAs) are used in most of these patients; however, they are being prescribed off label. METHODS: A literature revi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007581/ https://www.ncbi.nlm.nih.gov/pubmed/29955452 http://dx.doi.org/10.9740/mhc.2016.03.82 |
_version_ | 1783333065396846592 |
---|---|
author | Wasylyshen, Adrian Williams, Andrew M. |
author_facet | Wasylyshen, Adrian Williams, Andrew M. |
author_sort | Wasylyshen, Adrian |
collection | PubMed |
description | INTRODUCTION: Borderline personality disorder (BPD) is a personality disorder plagued with high rates of psychotropic polypharmacy. Estimates show that second-generation antipsychotics (SGAs) are used in most of these patients; however, they are being prescribed off label. METHODS: A literature review was conducted via PubMed in search for studies evaluating SGA use in BPD. RESULTS: There are available data investigating 8 of 11 SGAs and their use in BPD. Of N = 269 potential articles, N = 34 evaluating the use of SGAs in BPD were included. DISCUSSION: Strong evidence supporting SGAs in BPD is lacking. Potential target symptoms in which a SGA may be useful include depression, anxiety, anger, impulsivity, and paranoia/dissociative behavior. |
format | Online Article Text |
id | pubmed-6007581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | College of Psychiatric & Neurologic Pharmacists |
record_format | MEDLINE/PubMed |
spelling | pubmed-60075812018-06-28 Second-generation antipsychotic use in borderline personality disorder: What are we targeting? Wasylyshen, Adrian Williams, Andrew M. Ment Health Clin Personality Disorders INTRODUCTION: Borderline personality disorder (BPD) is a personality disorder plagued with high rates of psychotropic polypharmacy. Estimates show that second-generation antipsychotics (SGAs) are used in most of these patients; however, they are being prescribed off label. METHODS: A literature review was conducted via PubMed in search for studies evaluating SGA use in BPD. RESULTS: There are available data investigating 8 of 11 SGAs and their use in BPD. Of N = 269 potential articles, N = 34 evaluating the use of SGAs in BPD were included. DISCUSSION: Strong evidence supporting SGAs in BPD is lacking. Potential target symptoms in which a SGA may be useful include depression, anxiety, anger, impulsivity, and paranoia/dissociative behavior. College of Psychiatric & Neurologic Pharmacists 2016-03-08 /pmc/articles/PMC6007581/ /pubmed/29955452 http://dx.doi.org/10.9740/mhc.2016.03.82 Text en © 2016 CPNP. http://creativecommons.org/licenses/by-nc/3.0/ The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Personality Disorders Wasylyshen, Adrian Williams, Andrew M. Second-generation antipsychotic use in borderline personality disorder: What are we targeting? |
title | Second-generation antipsychotic use in borderline personality disorder: What are we targeting? |
title_full | Second-generation antipsychotic use in borderline personality disorder: What are we targeting? |
title_fullStr | Second-generation antipsychotic use in borderline personality disorder: What are we targeting? |
title_full_unstemmed | Second-generation antipsychotic use in borderline personality disorder: What are we targeting? |
title_short | Second-generation antipsychotic use in borderline personality disorder: What are we targeting? |
title_sort | second-generation antipsychotic use in borderline personality disorder: what are we targeting? |
topic | Personality Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007581/ https://www.ncbi.nlm.nih.gov/pubmed/29955452 http://dx.doi.org/10.9740/mhc.2016.03.82 |
work_keys_str_mv | AT wasylyshenadrian secondgenerationantipsychoticuseinborderlinepersonalitydisorderwhatarewetargeting AT williamsandrewm secondgenerationantipsychoticuseinborderlinepersonalitydisorderwhatarewetargeting |